Valuation Ipsen

Stocks

Real-time Euronext Paris 05:07:30 2026-08-17 am EDT			5-day change	1st Jan Change
160.30 ^EUR	+2.76%		+1.26%	+34.71%

Aug. 04	Marengo Therapeutics, Inc. and Ipsen S.A. Nominate First Drug Candidate Under Strategic Tristar Collaboration	CI
Aug. 03	Jefferies Downgrades Ipsen to Underperform, Boosts PT	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	6,621	8,279	8,912	9,155	9,770	12,790	-	-
Change	-	25.05%	7.65%	2.72%	6.72%	30.92%	-	-
Enterprise Value (EV) ¹	6,758	7,894	8,860	9,020	9,225	11,558	10,532	9,759
Change	-	16.81%	12.22%	1.81%	2.28%	25.28%	-8.87%	-7.35%
P/E	10.4x	12.9x	14x	26.7x	22.4x	12.8x	13.4x	13.3x
PBR	2.42x	-	2.36x	2.22x	2.3x	2.5x	2.12x	1.84x
PEG	-	20.02x	-13.67x	-0.6x	0.8x	0x	-3.35x	47.85x
Capitalization / Revenue	2.31x	2.74x	2.85x	2.69x	2.49x	2.81x	2.79x	2.68x
EV / Revenue	2.36x	2.61x	2.83x	2.65x	2.35x	2.54x	2.29x	2.04x
EV / EBITDA	5.8x	5.86x	10.1x	7.52x	6.67x	6.1x	6x	5.6x
EV / EBIT	6.68x	7.08x	8.85x	8.13x	7.13x	7.02x	7.07x	6.56x
EV / FCF	8.31x	9.02x	12.5x	11.6x	8.93x	8.96x	8.66x	7.94x
FCF Yield	12%	11.1%	8.02%	8.59%	11.2%	11.2%	11.5%	12.6%
Dividend per Share ²	1.2	1.2	1.2	1.4	1.4	1.535	1.532	1.655
Rate of return	1.49%	1.19%	1.11%	1.26%	1.18%	0.98%	0.98%	1.06%
EPS ²	7.76	7.81	7.73	4.15	5.32	12.15	11.66	11.69
Distribution rate	15.5%	15.4%	15.5%	33.7%	26.3%	12.6%	13.1%	14.1%
Net sales ¹	2,869	3,025	3,128	3,401	3,929	4,553	4,592	4,776
EBITDA ¹	1,166	1,348	881.4	1,200	1,383	1,895	1,754	1,744
EBIT ¹	1,011	1,115	1,001	1,109	1,294	1,647	1,491	1,488
Net income ¹	646.6	647.5	647.2	347.3	444.5	1,011	985.4	981.3
Net Debt ¹	137.8	-384.7	-52.9	-134.9	-544.5	-1,233	-2,258	-3,032
Reference price ²	80.50	100.50	107.90	110.70	119.00	156.00	156.00	156.00
Nbr of stocks (in thousands)	82,243	82,380	82,599	82,700	82,100	81,990	-	-
Announcement Date	2/11/22	2/9/23	2/8/24	2/13/25	2/12/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
IPSEN	12.84x	2.54x	6.1x	0.98%	14.81B
ELI LILLY AND COMPANY	33.76x	12.18x	24.85x	0.59%	1,052B
JOHNSON & JOHNSON	28.96x	-	-	2.06%	627B
ABBVIE INC.	31.84x	7.42x	15.42x	2.75%	441B
ROCHE HOLDING AG	19.79x	4.7x	11.65x	2.81%	349B
NOVARTIS AG	21.42x	5.54x	13.77x	2.89%	287B
ASTRAZENECA PLC	19.89x	4.11x	11.68x	2.14%	241B
AMGEN INC.	26.26x	6.84x	12.14x	2.43%	224B
NOVO NORDISK A/S	13.32x	4.79x	9.96x	3.83%	202B
GILEAD SCIENCES, INC.	-42.28x	6.13x	23.96x	2.38%	172B
Average	16.58x	6.03x	14.39x	2.29%	361B
Weighted average by Cap.	24.13x	8.01x	17.67x	1.99%